Literature DB >> 17507602

Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier.

Jan Michael Williams1, Mukut Sharma, Siddam Anjaiahh, John R Falck, Richard J Roman.   

Abstract

This study examined the metabolism of arachidonic acid (AA) by cytochrome P-450 enzymes in isolated glomeruli and the effects of selective inhibitors of the synthesis of 20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatetraenoic acids (EETs) on glomerular permeability to albumin (P(alb)). Glomeruli avidly produced 20-HETE, EETs, dihydroxyeicosatetraenoic acids (diHETEs), and HETEs when incubated with exogenous AA. N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine (HET0016; 10 microM) selectively inhibited the formation of 20-HETE by 95% and increased P(alb) from 0.00 +/- 0.08 to 0.73 +/- 0.10 (n = 43 glomeruli, 4 rats). Addition of a 20-HETE mimetic, 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid (20-5,14-HEDE; 1 microM) opposed the effects of HET0016 (10 microM) to increase P(alb) (0.21 +/- 0.10, n = 36 glomeruli, 4 rats). Preincubation of glomeruli with exogenous AA to increase basal production of 20-HETE had a similar effect. We also examined the effect of an epoxygenase inhibitor, N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide (MSPPOH; 5 microM), on P(alb). MSPPOH (5 microM) significantly increased P(alb) but had no effect on the synthesis of EETs in glomeruli incubated with AA. However, MSPPOH (5 microM) selectively reduced epoxygenase activity by 50% in glomeruli incubated without added AA. Pretreatment with 8,9-EET (100 nM) attenuated the effects of MSPPOH (5 microM) on P(alb). These results indicate that glomeruli produce 20-HETE, EETs, diHETEs, and HETEs and that endogenously formed 20-HETE and EETs play an essential role in the maintenance of the glomerular permeability barrier to albumin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507602      PMCID: PMC3146064          DOI: 10.1152/ajprenal.00131.2007

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  30 in total

1.  HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme.

Authors:  N Miyata; K Taniguchi; T Seki; T Ishimoto; M Sato-Watanabe; Y Yasuda; M Doi; S Kametani; Y Tomishima; T Ueki; M Sato; K Kameo
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

2.  Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis.

Authors:  Mauro Abbate; Carla Zoja; Marina Morigi; Daniela Rottoli; Stefania Angioletti; Susanna Tomasoni; Cristina Zanchi; Lorena Longaretti; Roberta Donadelli; Giuseppe Remuzzi
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 3.  Impaired renal autoregulation: implications for the genesis of hypertension and hypertension-induced renal injury.

Authors:  B F Palmer
Journal:  Am J Med Sci       Date:  2001-06       Impact factor: 2.378

4.  Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

Authors:  R Zatz; B R Dunn; T W Meyer; S Anderson; H G Rennke; B M Brenner
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

5.  Fenofibrate lowers blood pressure in two genetic models of hypertension.

Authors:  R K Shatara; D W Quest; T W Wilson
Journal:  Can J Physiol Pharmacol       Date:  2000-05       Impact factor: 2.273

6.  Transforming growth factor-beta1 increases albumin permeability of isolated rat glomeruli via hydroxyl radicals.

Authors:  R Sharma; A Khanna; M Sharma; V J Savin
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

7.  Vascular localization of soluble epoxide hydrolase in the human kidney.

Authors:  Zhigang Yu; Benjamin B Davis; Christophe Morisseau; Bruce D Hammock; Jean L Olson; Deanna L Kroetz; Robert H Weiss
Journal:  Am J Physiol Renal Physiol       Date:  2003-12-09

8.  20-hydroxyeicosatetraenoic acid (20-HETE): structural determinants for renal vasoconstriction.

Authors:  Ming Yu; Magdalena Alonso-Galicia; Cheng-Wen Sun; Richard J Roman; Naoya Ono; Hitomi Hirano; Tsuyoshi Ishimoto; Y Krishna Reddy; Kishta Reddy Katipally; Komandla Malla Reddy; V Raj Gopal; Ji Yu; Mohamed Takhi; J R Falck
Journal:  Bioorg Med Chem       Date:  2003-07-03       Impact factor: 3.641

Review 9.  Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.

Authors:  Richard W Snyder; Jeffrey S Berns
Journal:  Semin Dial       Date:  2004 Sep-Oct       Impact factor: 3.455

10.  A peroxisome proliferator-activated receptor-alpha activator induces renal CYP2C23 activity and protects from angiotensin II-induced renal injury.

Authors:  Dominik N Muller; Juergen Theuer; Erdenechimeg Shagdarsuren; Eva Kaergel; Horst Honeck; Joon-Keun Park; Marija Markovic; Eduardo Barbosa-Sicard; Ralf Dechend; Maren Wellner; Torsten Kirsch; Anette Fiebeler; Michael Rothe; Hermann Haller; Friedrich C Luft; Wolf-Hagen Schunck
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

View more
  22 in total

1.  Temporal characterization of the development of renal injury in FHH rats and FHH.1BN congenic strains.

Authors:  Jan Michael Williams; Marilyn Burke; Jozef Lazar; Howard J Jacob; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

Review 2.  Conflicting roles of 20-HETE in hypertension and renal end organ damage.

Authors:  Chao Zhang; George W Booz; Qing Yu; Xiaochen He; Shaoxun Wang; Fan Fan
Journal:  Eur J Pharmacol       Date:  2018-06-07       Impact factor: 4.432

Review 3.  Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.

Authors:  Fan Fan; Richard J Roman
Journal:  J Am Soc Nephrol       Date:  2017-07-12       Impact factor: 10.121

4.  Role of 20-HETE in the antihypertensive effect of transfer of chromosome 5 from Brown Norway to Dahl salt-sensitive rats.

Authors:  Jan M Williams; Fan Fan; Sydney Murphy; Carlos Schreck; Jozef Lazar; Howard J Jacob; Richard J Roman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-03-21       Impact factor: 3.619

5.  Cyp2c44 epoxygenase is essential for preventing the renal sodium absorption during increasing dietary potassium intake.

Authors:  Peng Sun; Joseph Antoun; Dao-Hong Lin; Peng Yue; Katherine H Gotlinger; Jorge Capdevila; Wen-Hui Wang
Journal:  Hypertension       Date:  2011-12-19       Impact factor: 10.190

6.  Altered renal hemodynamics is associated with glomerular lipid accumulation in obese Dahl salt-sensitive leptin receptor mutant rats.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Ashley C Johnson; Lateia Taylor; Cassandra Stubbs; Alyssa Nichols; Denise C Cornelius; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2020-02-18

7.  Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury.

Authors:  Jan Michael Williams; Albert Sarkis; Kimberly M Hoagland; Katherine Fredrich; Robert P Ryan; Carol Moreno; Bernardo Lopez; Jozef Lazar; Francisco J Fenoy; Mukut Sharma; Michael R Garrett; Howard J Jacob; Richard J Roman
Journal:  Am J Physiol Renal Physiol       Date:  2008-10-08

8.  Interaction of nitric oxide, 20-HETE, and EETs during functional hyperemia in whisker barrel cortex.

Authors:  Xiaoguang Liu; Chunyuan Li; John R Falck; Richard J Roman; David R Harder; Raymond C Koehler
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-23       Impact factor: 4.733

9.  8,9-Epoxyeicosatrienoic acid protects the glomerular filtration barrier.

Authors:  Mukut Sharma; Ellen T McCarthy; D Sudarshan Reddy; Paresh K Patel; Virginia J Savin; Meetha Medhora; John R Falck
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-06       Impact factor: 3.072

10.  Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy.

Authors:  Pengcheng Luo; Yiqiang Zhou; Hsin-Hsin Chang; Jie Zhang; Tsugio Seki; Cong-Yi Wang; Edward W Inscho; Mong-Heng Wang
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.